Authors


Wayne S. Fenton, MD

Latest:

Medication-Psychotherapy Combination Most Effective for Schizophrenia

"Can we talk?" asks a recovering patient who chastises psychiatry for too readily dismissing patients with her diagnosis as unable to benefit from talking therapy (A Recovering Patient, 1986). With managed care administrators quick to seize upon a lack of outcome data as a pretext for limiting treatment and a public mental health system pressed to handle caseloads as high as 200 to 300 patients per clinician, psychiatry's regrettable answer has often been: "No, we're too busy." Recent research findings, however, convincingly demonstrate that a flexible form of individual psychotherapy, when combined with appropriate neuroleptic medication, can yield improvements in social and vocational functioning unobtainable with "treatments as usual."


Wendy Froehlich, MD

Latest:

Autism Spectrum and Neurodevelopmental Disorders

This article aims to provide the general psychiatric community with an update on the major findings on the biology of ASDs as well as the advances in diagnostic and interventional strategies.


Wendy Haight, PhD

Latest:

Health and Psychiatric Issues in Children of Rural Methamphetamine Abusers and Manufacturers

Many abusers of methamphetamine in rural areas manufacture the drug for their personal use. These "mom-and-pop cooks" produce methamphetamine in and around homes where children are also living. This article provides an overview of the mental health of children whose parents abuse methamphetamine.


Wendy K. Silverman, PhD

Latest:

Using CBT in the Treatment of Social Phobia, Separation Anxiety and GAD

Children can now play a more active role in the treatment of their disorders. Using skills and information taught throughout the three treatment phases of cognitive-behavioral therapy (education, application and prevention relapse), they can be taught to understand and address the very fears that cause their disability.


Willem H. J. Martens, MD, PhD

Latest:

The Hidden Suffering of the Psychopath

The psychopath has the image of a cold, heartless, inhuman being. But do all psychopaths show a complete lack of normal emotional capacities and empathy?


William Bernet, MD

Latest:

Treatment of Parental Alienation: Guidelines for Mental Health and Legal Practitioners

Mental health clinicians and legal practitioners can learn more about parental alienation and its treatment here.


William C. Wirshing, MD

Latest:

Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics

Are the metabolic side effects of the atypical antipsychotics fueling the next round of malpractice suits being filed against psychiatrists? Guidelines are being created, but how can clinicians protect themselves and their patients, while continuing to give their patients the best care available?


William D. Dundon, PhD

Latest:

Comorbid Depression and Alcohol Dependence

Depression and alcoholism treatment requires the proper use of medication and psychosocial interventions, as well as a solid doctor-patient relationship and a commitment to treat both disorders.


William E. Reichman, MD

Latest:

Treating Cognition and Function in Patients With Alzheimer Disease

The cost-effectiveness of treatment for Alzheimer disease has been questioned. But until the next generation of therapeutics arrives, cholinesterase inhibitors and memantine will probably remain essential components of therapy for cognition and function.


William F. Pirl, MD, MPH

Latest:

Mini Quiz: Depression and Cancer

What is the estimated prevalence of psychiatric disorders in ambulatory patients with cancer? Find out in this quiz.


William Houghton, MD

Latest:

Label Me Not: Still Learning After All These Years

The world is a better place without a "tyrant of the day" taking over and cracking down with rigid rules. This and other life lessons after 40 years in psychiatry.


William K. Silverstein, BMSc

Latest:

The Current Status of Transcranial Direct Current Stimulation as a Treatment for Depression

Evidence has accumulated on the efficacy of transcranial direct current stimulation in major depression. The authors review its potential mechanism of action, findings from recent clinical trials, and potential role in the treatment of depressive disorders.


William M. Glazer, MD

Latest:

The Occupation of Psychiatry?

Should we accept the analysis of a journalist who has not treated a patient or implemented a study and reaches conclusions that run counter to well-established practice guidelines?


William M. Greenberg, MD

Latest:

Treatment Resistance in Schizophrenia: The Role of Alternative Therapies

In 1931, Gananath Sen and Kartick Chandra Bose reported on the use of an alkaloid extract from the Rauwolfia serpentina plant in the treatment of hypertension and "insanity with violent maniacal symptoms." They noted that dosages "of 20 to 30 grains of the powder twice daily produce not only a hypnotic effect but also a reduction of blood pressure and violent symptoms


William M. Lopez, MD

Latest:

Telepsychiatry: Watching Your Back While Staying in the Black

Telehealth is at a tipping point and is gaining momentum. Although there are some technological and logistical hurdles, most clinicians would likely find these to be minor and outweighed by the benefits of expanding access to mental health care to those in need.


William N. Goldstein, MD

Latest:

Dynamically Based Psychotherapy: A Contemporary Overview

This article addresses several important theoretical issues related to dynamically oriented psychotherapy. These issues include the therapeutic alliance and transference, the authority of the therapist and neutrality, the stability of the therapeutic environment, countertransference, empathy, and basic strategy. Efforts are made to present these issues in a contemporary context.



William R. Yates, MD

Latest:

A Neuroscientific-Medical Perspective

Recent research emphasizes our need for better understanding of the interface between the specialties of psychiatry and medicine. Psychiatrists need to monitor emerging work that highlights the need for both a neuroscientific and medical perspective in the management of complex disorders.


William S. Appleton, MD

Latest:

Psychiatric Tribalism

"Positive Psychology: A More Direct Route To Happiness" (Psychiatric Times, September 2007) brought to mind that no one asks an internist to which school of medicine he or she belongs.


William T. Carpenter, Jr, MD

Latest:

Psychotic Disorders in DSM-5: Clinical Implications of Revisions From DSM-IV

The authors discuss the clinical implications of the changes in the DSM-5 section on schizophrenia spectrum and other psychotic disorders.


William T. Carpenter, MD

Latest:

Criticism vs Fact: A Response To A Warning Sign on the Road to DSM-V by Allen Frances, MD

Allen Frances, an old friend, writes critically about the DSM-V project. I will address some key issues where his criticisms do not relate to reality as experienced from within the process. I chair the Psychoses Work Group and am a member of the DSM-V Task Force.


William T. Regenold, MD

Latest:

Sweet Sorrow: The Relationship Between Depression and Diabetes Mellitus

Multiple studies show that diabetes approximately doubles the risk of comorbid depression. Furthermore, major depressive disorder is a risk factor for the subsequent development of type 2 diabetes mellitus. Treatments for depression in the setting of diabetes must be evaluated for their effects on blood glucose levels, propensity for weight gain, possible concomitant use for diabetic neuropathy and potential drug interactions.


William V. Bobo, MD, MPH

Latest:

Mini Quiz: Long-Acting Injectables

When switching to this long-acting injectable antipsychotic, how long should an oral pre-switch antipsychotic be continued? Find out in this quiz.


William W. Dodson, MD

Latest:

Real-World Office Management of ADHD in Adults

Office management of attention-deficit/hyperactivity disorder (ADHD) differs in many important ways from ADHD management conducted in a research environment. In clinical trials, treatments and eligible patients are selected in advance by committees, patients are randomized to different management strategies, and both clinicians and pa tients are blinded to the treatments.


Willy Wilkinson, MPH

Latest:

Working With Transgender Persons

Using a question-and-answer format, we present a brief overview of issues that arise when mental health professionals explore how to best serve this population.


Wilson Compton, MD

Latest:

Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders

What is comorbidity? Psychiatric comorbidity refers to the occurrence of 2 or more mental or substance use disorders within a certain period. Research shows that comorbidity of substance use and other psychiatric disorders is common and often worsens the prognosis for each disorder.


Winfried Rief, PhD

Latest:

Somatoform and Related Disorders: An Update

Potentially over-inclusive DSM-5 diagnostic categories for somatic disorders can result in a confusing overlap of criteria. These authors sort through the challenges of the differential diagnosis-and map out a well-structured treatment plan.


Winnie To, BS

Latest:

Mini Quiz: Micronutrients and Depression

Micronutrient deficiencies can bring about a range of mental health complications. Take the quiz and learn more.


Yael Dvir, MD

Latest:

An Autistic Child With Psychotic Symptoms

Autism and schizophrenia may present as 2 separate disorders that need to be differentiated, or treated as comorbid conditions. It is important to remember that some individuals may have both disorders, which has implications when designing appropriate biopsychosocial interventions.


Yanni Rho, MD, MPH

Latest:

Rebels Without a Cause? Adolescents and Their Antiheroes

Adolescents reject their parents’ icons and seek out and empower their own. Antiheroes seem deliberately provocative, assailing almost every social convention of the adult generation, and parents often fear they are leading youth astray.

© 2024 MJH Life Sciences

All rights reserved.